Market Tracker

09/03 10:37am ET

NewLink Genetics Corp (NASDAQ:NLNK)

46.30
Delayed Data
As of Sep 02
 +2.94 / +6.78%
Today’s Change
17.32
Today|||52-Week Range
58.73
+16.48%
Year-to-Date

Today’s Trading

Previous close43.36
Today’s open43.96
Day’s range43.06 - 46.35
Volume323,900
Average volume (3 months)476,649
Market cap$1.2B
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-146.54%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio12.3
Price/Sales7.15
Price/Book5.65

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+1.43+3.87%
EBSEmergent BioSolution...+0.90+2.75%
HRTXHeron Therapeutics I...+1.37+3.83%
ZSPHZS Pharma Inc+3.47+6.82%
Data as of 09/02/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts